Advertisement

ISRG

Intuitive Surgical, Inc.

Healthcare · USD

Set alert

Price alert · ISRG

All alert types
432.01 USD -16.75 -3.73%
As of Oct 30, 2026 Extended hours 432.30 +0.07%
Bid
432.04 × 2
Ask
432.22 × 1
431.20 Day range 453.60
332.02 52-week range 592.85
YTD
-23.72%
1 year
-18.49%
Open
453.60
Prev close
448.76
Mkt cap
152.62B
Vol
3.48M
Avg vol
2.42M
EPS
8.27
P/E
52.24
Div yield
0.00%
More statistics
Low
431.20
High
453.60
Forward P/E
34.66
Beta
1.46
Short ratio
3.49
Inst. own
91.37%
Dividend
0.00
Ex-div date
Earnings
Jan 28, 2027
50-d avg
400.39
200-d avg
433.63
1y target
482.63

5D chart

Chart tools
Interval
ISRG five-day price chart431.2438.1445.0451.9458.8Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
152.49B
Enterprise value
151.65B
Trailing P/E
52.19
Forward P/E
34.66
PEG ratio
2.08
Price / sales
13.17
Price / book
9.36
EPS (TTM)
8.27
Beta
1.46
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
25.54%
Revenue (TTM)
11.58B
Revenue growth
21.70%
Free cash flow
3.43B
Total cash
4.04B
Total debt
0
Return on equity
17.93%
Shares outstanding
353.28M
Short % of float
2.08%
50-day average
400.39
200-day average
433.63

Analyst view

Consensus: buy

Buy
Price target (mean) 482.63 +11.7% upside
Target (low)
324.00
Target (mean)
482.63
Target (high)
685.00
Ratings (0m) 34 26 buy · 6 hold · 2 sell
  • Strong buy7
  • Buy19
  • Hold6
  • Sell1
  • Strong sell1

Next earnings

Jan 28, 2027

Expected Jan 28, 2027. Consensus EPS estimate 2.95.

Earnings history

Financials — quick view

All financials
ISRG Revenue — quarterly 3.05B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ISRG Net income — quarterly 522.80M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ISRG EPS — quarterly 1.50
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ISRG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 28, 2027Dec 30, 20262.97———
Oct 20, 2026Sep 30, 20262.653.00+0.35+13.21%
Jul 16, 2026Jun 30, 20262.512.80+0.29+11.55%
Apr 21, 2026Mar 31, 20262.512.80+0.29+11.55%
Jan 22, 2026Dec 31, 20252.272.53+0.26+11.45%
Oct 21, 2025Sep 30, 20251.992.40+0.41+20.60%

Upgrades / downgrades

ISRG analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026Leerink PartnersmainOutperformOutperform
Oct 21, 2026JP MorganmainOverweightOverweight
Oct 21, 2026Evercore ISI GroupmainIn-LineIn-Line
Oct 21, 2026Wells FargomainOverweightOverweight
Oct 21, 2026TD CowenreitBuyBuy
Oct 21, 2026BarclaysmainOverweightOverweight

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on ISRG — it syncs with the Stock Master app.

Insider holders

ISRG insider holders
InsiderRelationLatest transactionDateShares held
BARRATT CRAIG HDirectorSaleOct 22, 202627,948
CHARLTON HENRY LOfficerConversion of Exercise of derivative securityFeb 26, 202611,610
GUTHART GARY SDirectorSaleOct 22, 20260
JEDDI IMANOfficerSaleMay 31, 202633,112
JOHNSON AMAL MDirectorConversion of Exercise of derivative securityApr 29, 202613,545
LOEB GARYOfficerConversion of Exercise of derivative securityOct 8, 20266,636

Institution ownership

ISRG institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.66%30,024,64812.96BJun 29, 2026
Vanguard Capital Management LLC6.67%23,131,0999.98BJun 29, 2026
State Street Corporation4.63%16,063,0406.93BJun 29, 2026
Invesco Ltd.3.42%11,843,5635.11BJun 29, 2026
Price (T.Rowe) Associates Inc3.25%11,256,5704.86BJun 29, 2026
Geode Capital Management, LLC2.46%8,534,7673.68BJun 29, 2026

Fund ownership

ISRG fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.24%11,243,4684.85BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.65%9,176,4093.96BJun 29, 2026
Invesco QQQ Trust, Series 12.13%7,379,1133.19BSep 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.36%4,707,5332.03BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.33%4,597,3551.98BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.26%4,370,7461.89BSep 29, 2026
Advertisement